vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Civeo Corp (CVEO). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $161.6M, roughly 1.3× Civeo Corp). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -4.0%, a 12.3% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 7.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $14.5M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -1.4%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
COLL vs CVEO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $161.6M |
| Net Profit | $17.0M | $-6.5M |
| Gross Margin | 62.5% | 22.7% |
| Operating Margin | 29.6% | -0.1% |
| Net Margin | 8.3% | -4.0% |
| Revenue YoY | 12.9% | 7.1% |
| Net Profit YoY | 35.3% | 58.1% |
| EPS (diluted) | $0.48 | $-0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $161.6M | ||
| Q3 25 | $209.4M | $170.5M | ||
| Q2 25 | $188.0M | $162.7M | ||
| Q1 25 | $177.8M | $144.0M | ||
| Q4 24 | $181.9M | $151.0M | ||
| Q3 24 | $159.3M | $176.3M | ||
| Q2 24 | $145.3M | $188.7M | ||
| Q1 24 | $144.9M | $166.1M |
| Q4 25 | $17.0M | $-6.5M | ||
| Q3 25 | $31.5M | $-455.0K | ||
| Q2 25 | $12.0M | $-3.3M | ||
| Q1 25 | $2.4M | $-9.8M | ||
| Q4 24 | $12.5M | $-15.4M | ||
| Q3 24 | $9.3M | $-5.1M | ||
| Q2 24 | $19.6M | $8.2M | ||
| Q1 24 | $27.7M | $-5.1M |
| Q4 25 | 62.5% | 22.7% | ||
| Q3 25 | 61.7% | 25.7% | ||
| Q2 25 | 57.7% | 25.3% | ||
| Q1 25 | 54.8% | 20.4% | ||
| Q4 24 | 54.0% | 18.6% | ||
| Q3 24 | 60.8% | 21.4% | ||
| Q2 24 | 62.5% | 25.4% | ||
| Q1 24 | 63.1% | 21.5% |
| Q4 25 | 29.6% | -0.1% | ||
| Q3 25 | 29.7% | 4.1% | ||
| Q2 25 | 18.7% | 1.7% | ||
| Q1 25 | 12.2% | -3.8% | ||
| Q4 24 | 20.9% | -6.7% | ||
| Q3 24 | 21.9% | 0.0% | ||
| Q2 24 | 32.7% | 6.9% | ||
| Q1 24 | 34.1% | -1.1% |
| Q4 25 | 8.3% | -4.0% | ||
| Q3 25 | 15.0% | -0.3% | ||
| Q2 25 | 6.4% | -2.0% | ||
| Q1 25 | 1.4% | -6.8% | ||
| Q4 24 | 6.9% | -10.2% | ||
| Q3 24 | 5.9% | -2.9% | ||
| Q2 24 | 13.5% | 4.4% | ||
| Q1 24 | 19.1% | -3.1% |
| Q4 25 | $0.48 | $-0.58 | ||
| Q3 25 | $0.84 | $-0.04 | ||
| Q2 25 | $0.34 | $-0.25 | ||
| Q1 25 | $0.07 | $-0.72 | ||
| Q4 24 | $0.36 | $-1.04 | ||
| Q3 24 | $0.27 | $-0.36 | ||
| Q2 24 | $0.52 | $0.56 | ||
| Q1 24 | $0.71 | $-0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $14.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $174.4M |
| Total Assets | $1.7B | $477.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $14.4M | ||
| Q3 25 | $285.9M | $12.0M | ||
| Q2 25 | $222.2M | $14.6M | ||
| Q1 25 | $197.8M | $28.4M | ||
| Q4 24 | $162.8M | $5.2M | ||
| Q3 24 | $120.0M | $17.9M | ||
| Q2 24 | $271.6M | $7.4M | ||
| Q1 24 | $318.0M | $16.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $43.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $301.7M | $174.4M | ||
| Q3 25 | $274.8M | $182.5M | ||
| Q2 25 | $232.2M | $209.4M | ||
| Q1 25 | $234.4M | $220.7M | ||
| Q4 24 | $228.8M | $236.4M | ||
| Q3 24 | $234.3M | $282.2M | ||
| Q2 24 | $216.6M | $297.4M | ||
| Q1 24 | $222.2M | $297.4M |
| Q4 25 | $1.7B | $477.4M | ||
| Q3 25 | $1.6B | $491.1M | ||
| Q2 25 | $1.6B | $508.8M | ||
| Q1 25 | $1.6B | $423.8M | ||
| Q4 24 | $1.7B | $405.1M | ||
| Q3 24 | $1.6B | $477.6M | ||
| Q2 24 | $1.1B | $483.2M | ||
| Q1 24 | $1.1B | $513.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $19.3M |
| Free Cash FlowOCF − Capex | $122.4M | $14.5M |
| FCF MarginFCF / Revenue | 59.6% | 8.9% |
| Capex IntensityCapex / Revenue | 0.3% | 3.0% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $19.3M | ||
| Q3 25 | $78.4M | $13.8M | ||
| Q2 25 | $72.4M | $-2.3M | ||
| Q1 25 | $55.4M | $-8.4M | ||
| Q4 24 | $84.6M | $9.5M | ||
| Q3 24 | $-9.0M | $35.7M | ||
| Q2 24 | $67.4M | $32.4M | ||
| Q1 24 | $61.9M | $6.0M |
| Q4 25 | $122.4M | $14.5M | ||
| Q3 25 | $78.3M | $8.2M | ||
| Q2 25 | $72.4M | $-6.8M | ||
| Q1 25 | $54.6M | $-13.7M | ||
| Q4 24 | $84.1M | $1.8M | ||
| Q3 24 | $-9.2M | $28.2M | ||
| Q2 24 | $67.1M | $27.0M | ||
| Q1 24 | $61.4M | $372.0K |
| Q4 25 | 59.6% | 8.9% | ||
| Q3 25 | 37.4% | 4.8% | ||
| Q2 25 | 38.5% | -4.2% | ||
| Q1 25 | 30.7% | -9.5% | ||
| Q4 24 | 46.2% | 1.2% | ||
| Q3 24 | -5.8% | 16.0% | ||
| Q2 24 | 46.2% | 14.3% | ||
| Q1 24 | 42.3% | 0.2% |
| Q4 25 | 0.3% | 3.0% | ||
| Q3 25 | 0.1% | 3.3% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.4% | 3.7% | ||
| Q4 24 | 0.3% | 5.1% | ||
| Q3 24 | 0.2% | 4.2% | ||
| Q2 24 | 0.2% | 2.8% | ||
| Q1 24 | 0.4% | 3.4% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 3.93× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
